// App-Quantinova.ai

295 : Large-Scale High Resolution Integration of Copy Number and Gene Expression in DLBCL Reveals Focal and Frequent Deletions in Chromatin Modifying Genes with Outcome Correlation

Researchers

Presenter

  • Susana Ben-Neriah

Principal Investigators

  • Raymond Lim

  • Joseph M. Connors

  • Marco A. Marra

  • Randy D. Gascoyne

  • Sohrab P Shah

  • Christian Steidl

  • Sandy Hu

  • Sanja Rogic

  • Nathalie Johnson

  • Ryan D Morin

  • Gavin Ha

  • Jiraui Ding

  • David W. Scott

  • Laurie H. Sehn

Medical Centers

  • Molecular Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  • Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada

  • Bioinformatics Training Program, University of British Columbia, Vancouver, BC, Canada

  • Department of Oncology, Jewish General Hospital, Montreal, QC, Canada

  • Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  • Department of Medical Oncology, BC Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada

  • Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • B-cell lymphoma 6

  • beta-2 microglobulin

  • Cyclin Dependent Kinase Inhibitor 2A

  • Transducin Beta Like 1 X-Linked Receptor 1

  • Tumor protein p63

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Vincristine

  • Doxorubicin

  • Prednisone

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved